The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of the combination of temozolomide (TM) and pazopanib (PZ) in advanced pancreatic neuroendocrine tumors (PNETs) (NCT01465659).
 
Manali A. Bhave
No Relationships to Disclose
 
Sheetal Mehta Kircher
No Relationships to Disclose
 
Aparna Kalyan
Honoraria - Samumed
Research Funding - Bristol-Myers Squibb (Inst)
 
Jordan Berlin
Honoraria - genentech; Nestle health science
Consulting or Advisory Role - Aduro Biotech; BeiGene; Celgene; Cornerstone Pharmaceuticals; EMD Serono; ERYTECH Pharma; Exelixis; Five Prime Therapeutics; Genentech/Roche; Gritstone Bio; Karyopharm Therapeutics; Opsona Therapeutics; Pierre Fabre; Symphony Evolution
Research Funding - Abbvie (Inst); Bayer (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Loxo (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Symphony Evolution (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Celgene; EMD Serono; Genentech/Roche; Nestle health science
Other Relationship - AstraZeneca; Symphony Evolution
 
Mary Frances Mulcahy
No Relationships to Disclose
 
Steven J. Cohen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Genentech; Taiho Pharmaceutical
 
Crystal S. Denlinger
Consulting or Advisory Role - Carevive Systems; EMD Serono; Lilly; Merck; Merrimack
Research Funding - Advaxis (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst)
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene; Five Prime Therapeutics; Genentech/Roche; Halozyme; Vicus Therapeutics
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche
 
Vaibhav Sahai
Honoraria - Celgene; Halozyme; Merrimack; Newlink Genetics
Consulting or Advisory Role - Celgene
Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Incyte (Inst)
 
Mark Zalupski
Research Funding - Halozyme; Newlink Genetics/Pharmatech; Oncomed
 
Alfred Rademaker
Research Funding - Siemens (Inst)
Other Relationship - Georgetown Univ.; JAMA-Journal of the American Medical Association
 
Al Bowen Benson
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; EMD Serono; Exelixis; Genentech/Roche; Guardant Health; Guerbet; Halozyme; Helsinn Healthcare; Immunogen; IntegraGen; Lexicon; Lilly; Novartis; Oncosil; Opsona Therapeutics; Pfizer; Purdue Pharma; Rafael Pharmaceuticals; Taiho Pharmaceutical; TRM Oncology
Research Funding - Acerta Pharma; advanced accelerator applications (Inst); Bristol-Myers Squibb; Celgene; Infinity Pharmaceuticals (Inst); MedImmune; Merck Sharp & Dohme (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Xencor; Xencor
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Dava Oncology; Genentech/Roche; Gilead Sciences; Guardant Health; guerbet; Helsinn Healthcare; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals; TRM Oncology
 
Halla Nimeiri
Speakers' Bureau - Genentech/Roche